4//SEC Filing
Sullivan Lara 4
Accession 0000950170-25-048905
CIK 0001782223other
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 9:06 AM ET
Size
5.4 KB
Accession
0000950170-25-048905
Insider Transaction Report
Form 4
Sullivan Lara
DirectorPresident ,CEO & CMO
Transactions
- Award
Stock Option (Right to Buy)
2025-03-31$0.98/sh+918,308$899,942→ 918,308 totalExercise: $0.98Exp: 2035-03-31→ Common Stock (918,308 underlying)
Footnotes (1)
- [F1]The shares subject to this option will vest over four years, with 25% vesting on the first anniversary of March 31,2025 and the remainder vesting in 36 equal monthly instalments thereafter subject to the reporting person's continued employment through the applicable vesting date.
Documents
Issuer
Pyxis Oncology, Inc.
CIK 0001782223
Entity typeother
Related Parties
1- filerCIK 0001769457
Filing Metadata
- Form type
- 4
- Filed
- Apr 1, 8:00 PM ET
- Accepted
- Apr 2, 9:06 AM ET
- Size
- 5.4 KB